{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T06:58:24Z","timestamp":1655881104831},"reference-count":0,"publisher":"Japanese Leprosy Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese journal of leprosy"],"published-print":{"date-parts":[[2004]]},"DOI":"10.5025\/hansen.73.235","type":"journal-article","created":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T04:33:42Z","timestamp":1283229222000},"page":"235-244","source":"Crossref","is-referenced-by-count":1,"title":["New Pharmacological Availability of Thalidomide Based on the Experiences in Patients with Multiple Myeloma."],"prefix":"10.5025","volume":"73","author":[{"given":"Hirokazu","family":"Murakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2941","container-title":["Japanese journal of leprosy"],"original-title":["\u30b5\u30ea\u30c9\u30de\u30a4\u30c9\u306e\u65b0\u3057\u3044\u85ac\u7406\u5b66\uff1a\u591a\u767a\u6027\u9aa8\u9ac4\u816b\u306e\u6cbb\u7642\u7d4c\u9a13\u304b\u3089"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T18:54:24Z","timestamp":1621536864000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/hansen1996\/73\/3\/73_3_235\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.5025\/hansen.73.235","relation":{},"ISSN":["1342-3681","1884-314X"],"issn-type":[{"value":"1342-3681","type":"print"},{"value":"1884-314X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004]]}}}